Keywords
Abstract
Ushbu maqola antibiotiklarga chidamlilik (rezistentlik) global tibbiy inqiroz ekanligini ta'kidlaydi. Unda ushbu muammoning biologik mexanizmi (mutatsiya va gorizontal gen uzatish), chidamlilikni keltirib chiqaruvchi asosiy omillar (tibbiyotda, chorvachilikda noto'g'ri qo'llash va gigiyena muammolari) yoritilgan. Shuningdek, maqolada chidamlilikning oqibatlari — o'lim darajasining ortishi, tibbiy amaliyotlarning xavf ostida qolishi va iqtisodiy zararlar ko'rsatib o'tilgan. Maqola yakunida inqirozga qarshi kurashish uchun umumiy strategiyalar (to'g'ri qo'llash, gigiyena, ilmiy tadqiqotlarga investitsiya) zarurligi ta'kidlanadi.References
Xalqaro Tashkilotlar Hujjatlari
1. Jahon Sog'liqni Saqlash Tashkiloti (JSST / WHO)
2. World Health Organization (WHO). (2020). Antimicrobial Resistance: Global Report on Surveillance 2020. Retrieved from https://www.who.int
3. Centers for Disease Control and Prevention (CDC). (2019). Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: U.S. Department of Health and Human Services.
4. The Lancet. (2022). Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet, 399(10325), 629–655.
5. O'Neill, J. (2016). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations on Antimicrobial Resistance. The Review on Antimicrobial Resistance. London: HM Government and Wellcome Trust.
6. Dudley, M. N., & Wentworth, C. C. (2020). Antibiotic Resistance: A Global Health Crisis. In Principles and Practice of Infectious Diseases (9th ed., Vol. 1, pp. 317-331). Elsevier.
7. United Nations. (2016). Political Declaration of the High-Level Meeting of the General Assembly on Antimicrobial Resistance. A/RES/71/3. New York: United Nations.
8. World Bank. (2017). Drug-Resistant Infections: A Threat to Our Economic Future. Washington, DC: World Bank Publications.